| Title |
Exposure to Infliximab During Pregnancy: Post-Marketing Experience
|
|---|---|
| Published in |
Drug Safety, November 2019
|
| DOI | 10.1007/s40264-019-00881-8 |
| Pubmed ID | |
| Authors |
Anja Geldhof, Jennifer Slater, Michael Clark, Urmila Chandran, Danielle Coppola |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 20% |
| United States | 1 | 20% |
| Sweden | 1 | 20% |
| Japan | 1 | 20% |
| Unknown | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 2 | 40% |
| Members of the public | 2 | 40% |
| Scientists | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 85 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 10 | 12% |
| Student > Master | 8 | 9% |
| Researcher | 6 | 7% |
| Student > Bachelor | 5 | 6% |
| Student > Doctoral Student | 4 | 5% |
| Other | 15 | 18% |
| Unknown | 37 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 25 | 29% |
| Nursing and Health Professions | 5 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 6% |
| Unspecified | 4 | 5% |
| Agricultural and Biological Sciences | 1 | 1% |
| Other | 8 | 9% |
| Unknown | 37 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 December 2019.
All research outputs
#13,081,057
of 23,172,045 outputs
Outputs from Drug Safety
#1,209
of 1,711 outputs
Outputs of similar age
#168,278
of 362,940 outputs
Outputs of similar age from Drug Safety
#8
of 24 outputs
Altmetric has tracked 23,172,045 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,711 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,940 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.